English
Insider transactions
EDGARMEDICUS PHARMA LTD.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-17.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–49 of 49
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 Filed 2026-09-08 | Bonner Carolyn F. Officer: President and CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,470,588 | 0.1705 | 250,735.254Derived: shares × price per share. Exact value 250735.2540. | 1,489,493 | Direct (D) | No | — | Open filing 0000950142-26-002519 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Bonner Carolyn F. Officer: President and CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 250,000 | 0 | — | 250,000 | Direct (D) | No | F1
| Open filing 0000950142-26-002519 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Smith Andrew Alasdair Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 735,294 | 0.1705 | 125,367.627Derived: shares × price per share. Exact value 125367.6270. | 735,458 | Direct (D) | No | — | Open filing 0000950142-26-002522 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Smith Andrew Alasdair Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 125,000 | 0 | — | 125,000 | Direct (D) | No | F1
| Open filing 0000950142-26-002522 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Brennan Edward J. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 588,235 | 0.1705 | 100,294.0675Derived: shares × price per share. Exact value 100294.0675. | 674,735 | Direct (D) | No | — | Open filing 0000950142-26-002520 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Brennan Edward J. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | 0 | — | 100,000 | Direct (D) | No | F1
| Open filing 0000950142-26-002520 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Bokhari Raza Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 2,941,176 | 0.1705 | 501,470.508Derived: shares × price per share. Exact value 501470.5080. | 2,941,176 | Direct (D) | No | — | Open filing 0000950142-26-002518 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Bokhari Raza Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 500,000 | 0 | — | 500,000 | Direct (D) | No | F1
| Open filing 0000950142-26-002518 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Mehmud Faisal Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,470,588 | 0.1705 | 250,735.254Derived: shares × price per share. Exact value 250735.2540. | 1,470,588 | Direct (D) | No | — | Open filing 0000950142-26-002521 Read from the filing’s XML Dispute this row |
| 2026-09-04 Filed 2026-09-08 | Mehmud Faisal Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 250,000 | 0 | — | 250,000 | Direct (D) | No | F1
| Open filing 0000950142-26-002521 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Rodgers Cathy McMorris Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001642 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | FISHMAN BARRY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001636 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | MAHAFFY PATRICK J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001638 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Brennan Edward J. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001634 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Ciaruffoli Robert J. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001635 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Bokhari Raza Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 500,000 | 0 | — | 500,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001632 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Bonner Carolyn F. Officer: President and CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 250,000 | 0 | — | 250,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001633 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | May Sara R. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001639 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Raju Ajay Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001641 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Smith Andrew Alasdair Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 200,000 | 0 | — | 200,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001643 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Ashton William Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001631 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Kaiser Larry Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001637 Read from the filing’s XML Dispute this row |
| 2026-06-03 Filed 2026-06-04 | Mehmud Faisal Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 250,000 | 0 | — | 250,000 | Direct (D) | No | F1
| Open filing 0000950142-26-001640 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Rodgers Cathy McMorris Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001032 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | May Sara R. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001029 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Raju Ajay Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001031 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Bokhari Raza Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 325,000 | 0 | — | 325,000 | Direct (D) | No | — | Open filing 0000950142-26-001022 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Kaiser Larry Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001027 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Mehmud Faisal Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 125,000 | 0 | — | 125,000 | Direct (D) | No | — | Open filing 0000950142-26-001030 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Brennan Edward J. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001024 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Ciaruffoli Robert J. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001025 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Ashton William Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001021 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | MAHAFFY PATRICK J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001028 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Bonner Carolyn F. Officer: President and CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 100,000 | 0 | — | 100,000 | Direct (D) | No | — | Open filing 0000950142-26-001023 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | FISHMAN BARRY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | — | Open filing 0000950142-26-001026 Read from the filing’s XML Dispute this row |
| 2026-03-30 Filed 2026-04-01 | Smith Andrew Alasdair Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | — | Open filing 0000950142-26-001033 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Smith Andrew Alasdair Officer: Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003241 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Mehmud Faisal Officer: Chief Medical Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 75,000 | 0 | — | 75,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003238 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | May Sara R. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003237 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Rodgers Cathy McMorris Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003240 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Kaiser Larry Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003235 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | MAHAFFY PATRICK J Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003236 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Brennan Edward J. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0 | — | 50,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003232 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Bokhari Raza Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 125,000 | 0 | — | 125,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003230 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Ashton William Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003229 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Bonner Carolyn F. Officer: President and CFO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 75,000 | 0 | — | 75,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003231 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Raju Ajay Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003239 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | Ciaruffoli Robert J. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003233 Read from the filing’s XML Dispute this row |
| 2025-12-16 Filed 2025-12-18 | FISHMAN BARRY Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 25,000 | 0 | — | 25,000 | Direct (D) | No | F1
| Open filing 0000950142-25-003234 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-16. Prior quarter ending 2026-06-30: 9,150 filings read.
Showing 1–24 of 24
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Interchange Capital Partners, LLC | 2,124,910 SH | 342,879 dollars | Higher by 538,039 Prior quarter: 1,586,871 | Open filing 0001845998-26-000006 Filed 2026-10-28 Dispute this row |
| Private Advisor Group, LLC | 273,555 SH | 50,089 dollars | Not in the prior quarter’s filings read | Open filing 0001567755-26-000005 Filed 2026-11-10 Dispute this row |
| JANE STREET GROUP, LLC Partly reported under another manager | 181,613 SH | 29,239 dollars | Lower by 152,060 Prior quarter: 333,673 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| Sterling Investment Advisors, Ltd. | 100,000 SH | 16,100 dollars | Unchanged Prior quarter: 100,000 | Open filing 0001701132-26-000005 Filed 2026-10-27 Dispute this row |
| UBS Group AG Partly reported under another manager | 83,489 SH | 13,689 dollars | Higher by 81,286 Prior quarter: 2,203 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| COMMONWEALTH EQUITY SERVICES, LLC Partly reported under another manager | 73,863 SH | 11,890 dollars | Higher by 21,220 Prior quarter: 52,643 | Open filing 0000312272-26-000024 Filed 2026-11-02 Dispute this row |
| May Hill Capital, LLC | 50,622 SH | 8,150 dollars | Unchanged Prior quarter: 50,622 | Open filing 0001754960-26-000973 Filed 2026-11-03 Dispute this row |
| Anson Funds Management LP | 42,400 SH | 12,720 dollars | Unchanged Prior quarter: 42,400 | Open filing 0001193125-26-460605 Filed 2026-11-13 Dispute this row |
| STIFEL FINANCIAL CORP Partly reported under another manager | 30,000 SH | 4,830 dollars | Unchanged Prior quarter: 30,000 | Open filing 0000720672-26-000017 Filed 2026-11-12 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 25,658 SH | 4,018 dollars | Higher by 36 Prior quarter: 25,622 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| Wilmington Savings Fund Society, FSB Partly reported under another manager | 25,622 SH | 4,125 dollars | Unchanged Prior quarter: 25,622 | Open filing 0000900974-26-000008 Filed 2026-10-23 Dispute this row |
| Smithfield Trust Co | 24,614 SH | 4 dollars | Unchanged Prior quarter: 24,614 | Open filing 0001019754-26-000005 Filed 2026-11-09 Dispute this row |
| Sound View Wealth Advisors Group, LLC | 17,000 SH | 2,737 dollars | Not in the prior quarter’s filings read | Open filing 0001784777-26-000003 Filed 2026-11-10 Dispute this row |
| Summit Global Investments | 15,000 SH | 2 dollars | Not in the prior quarter’s filings read | Open filing 0001697953-26-000007 Filed 2026-10-28 Dispute this row |
| LPL Financial LLC | 11,012 SH | 1,773 dollars | Lower by 6,500 Prior quarter: 17,512 | Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row |
| Foundations Investment Advisors, LLC | 11,000 SH | 1,771 dollars | Unchanged Prior quarter: 11,000 | Open filing 0001743404-26-000009 Filed 2026-11-12 Dispute this row |
| StoneX Group Inc. Partly reported under another manager | 10,965 SH | 1,765 dollars | Lower by 6,101 Prior quarter: 17,066 | Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row |
| STALEY CAPITAL ADVISERS INC | 10,000 SH | 1,610 dollars | Not in the prior quarter’s filings read | Open filing 0001106565-26-000010 Filed 2026-11-06 Dispute this row |
| OSAIC HOLDINGS, INC. Partly reported under another manager | 7,500 SH | 1,200 dollars | Unchanged Prior quarter: 7,500 | Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row |
| Global Retirement Partners, LLC | 1,000 SH | 161 dollars | Not in the prior quarter’s filings read | Open filing 0001580642-26-007620 Filed 2026-11-10 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 1,000 SH | 161 dollars | Lower by 22 Prior quarter: 1,022 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| HAZLETT, BURT WATSON, INC. | 425 SH | 0 dollars | Unchanged Prior quarter: 425 | Open filing 0000046392-26-000006 Filed 2026-11-04 Dispute this row |
| BOLTON SECURITIES CORPORATION | 100 SH | 16 dollars | Unchanged Prior quarter: 100 | Open filing 0001457457-26-000016 Filed 2026-11-12 Dispute this row |
| JONES FINANCIAL COMPANIES LLLP Partly reported under another manager | 0 SH | 0 dollars | Lower by 400 Prior quarter: 400 | Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- XTX Topco Ltd 243,362 SH
- ARMISTICE CAPITAL, LLC 60,600 SH
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 31,462 SH
- CITADEL ADVISORS LLC 25,102 SH
- Stratos Wealth Partners, LTD. 20,950 SH
- MARATHON CAPITAL MANAGEMENT 15,500 SH
- Connective Capital Management, LLC 6,000 SH
- ROYAL BANK OF CANADA 1,055 SH
- MERCER GLOBAL ADVISORS INC /ADV 500 SH
- WELLS FARGO COMPANY/MN 200 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Melani Kenneth R. Common Shares, no par value | 3.6 | 3,248,741.00 | 09/30/2026 Filed 2026-10-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0000950142-26-002781 Dispute this row |
| VELOCITY FUND PARTNERS, LP Common Shares, no par value | 3.2 | 2,839,330.00 | 09/30/2026 Filed 2026-10-16 | SCHEDULE 13G/AAmendment 2 | Open filing 0000950142-26-002781 Dispute this row |
| BOKHARI, RAZA Common shares, no par value | 5.3 | 4,859,349.00 | 09/04/2026 Filed 2026-09-14 | SCHEDULE 13D | Open filing 0000950142-26-002546 Dispute this row |
| RBx Capital, LP Common shares, no par value | 0.9 | 793,173.00 | 09/04/2026 Filed 2026-09-14 | SCHEDULE 13D | Open filing 0000950142-26-002546 Dispute this row |
| Raju Ajay Common Shares, no par value per share | 3.7 | 2,031,250.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-26-001279 Dispute this row |
| 215 Capital Togo PHL Fund I, LP Common Shares, no par value per share | 3.6 | 2,000,000.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-26-001279 Dispute this row |
| Togo PHL Management LLC Common Shares, no par value per share | 3.6 | 2,000,000.00 | 03/31/2026 Filed 2026-05-05 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-26-001279 Dispute this row |
| Bokhari Raza Common shares, no par value | 4.8 | 1,218,173.00 | 12/31/2025 Filed 2026-01-05 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-26-000046 Dispute this row |
| RBx Capital, LP Common shares, no par value | 3.2 | 793,173.00 | 12/31/2025 Filed 2026-01-05 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-26-000046 Dispute this row |
| Armistice Capital, LLC Common shares, no par value | 4.99 | 935,724.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-25-003590 Dispute this row |
| Steven Boyd Common shares, no par value | 4.99 | 935,724.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001172661-25-003590 Dispute this row |
| Melani Kenneth R. Common Shares, no par value | 18.2 | 3,248,741.00 | 06/30/2025 Filed 2025-08-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-25-002133 Dispute this row |
| VELOCITY FUND PARTNERS, LP Common Shares, no par value | 15.9 | 2,839,330.00 | 06/30/2025 Filed 2025-08-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-25-002133 Dispute this row |
| John Hathaway Common shares, no par value | 4.5 | 800,952.00 | 06/30/2025 Filed 2025-08-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-25-002132 Dispute this row |
| SkinJect Partners LLC Common shares, no par value | 4.5 | 800,952.00 | 06/30/2025 Filed 2025-08-12 | SCHEDULE 13G/AAmendment 1 | Open filing 0000950142-25-002132 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,139,981 filings read, dated 2004-06-14 to 2026-11-16: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 63,366 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 254,873 |
Filings made before the SEC required XML are listed, not extracted.